宣泰医药(688247)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688247 宣泰医药

已收盘 09-18 15:00:00

{"stockData":{"symbol":"688247","market":"SH","secType":"STK","nameCN":"宣泰医药","latestPrice":10.94,"timestamp":1758178800000,"preClose":11.16,"halted":0,"volume":4849039,"delay":0,"changeRate":-0.0197,"floatShares":453000000,"shares":453000000,"eps":0.2628,"marketStatus":"已收盘","change":-0.22,"latestTime":"09-18 15:00:00","open":11.15,"high":11.23,"low":10.82,"amount":53677600,"amplitude":0.0367,"askPrice":10.95,"askSize":49,"bidPrice":10.94,"bidSize":48,"shortable":0,"etf":0,"ttmEps":0.2628,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1758245400000},"marketStatusCode":5,"adr":0,"adjPreClose":11.16,"symbolType":"stock_kcb","openAndCloseTimeList":[[1758159000000,1758166200000],[1758171600000,1758178800000]],"highLimit":12.28,"lowLimit":10.04,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":453340000,"isCdr":false,"pbRate":3.81,"roa":"--","peRate":41.628615,"roe":"3.53%","epsLYR":0.28,"committee":-0.208995,"marketValue":4960000000,"turnoverRate":0.0107,"status":1,"afterMarket":{"amount":0,"volume":0,"close":10.94,"buyVolume":0,"sellVolume":0,"time":1758180839260,"indexStatus":"已收盘 09-18 15:30:00","preClose":11.16},"floatMarketCap":4960000000},"requestUrl":"/m/hq/s/688247","defaultTab":"news","newsList":[{"id":"2567644139","title":"每周股票复盘：宣泰医药（688247）上半年净利降15.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567644139","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567644139?lang=zh_cn&edition=full","pubTime":"2025-09-14 05:49","pubTimestamp":1757800152,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘，宣泰医药报收于11.18元，较上周的11.04元上涨1.27%。本周，宣泰医药9月12日盘中最高价报11.26元。宣泰医药当前最新总市值50.37亿元，在化学制药板块市值排名106/150，在两市A股市值排名3296/5153。2025年上半年，公司实现营业收入2.196亿元，同比增长0.74%；净利润为4558.57万元，同比下降15.82%，主要因泊沙康唑肠溶片未中标集采及美沙拉秦肠溶片美国市场销售下滑。研发投入占比较上年同期下降，为11.70%。公司无重大违规行为，无重大风险未披露事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400001470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688247"],"gpt_icon":0},{"id":"2562929892","title":"宣泰医药（688247）3.11亿股限售股将于8月25日解禁，占总股本68.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562929892","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562929892?lang=zh_cn&edition=full","pubTime":"2025-08-25 08:03","pubTimestamp":1756080198,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，宣泰医药于8月25日将有3.11亿股限售股份解禁，为公司首发原股东限售股份，占公司总股本68.61%。最近一年内，该股累计解禁226.7万股，占总股本的0.5%。宣泰医药主营业务：自主实现高技术壁垒的仿制药的研发、产品注册申报、生产与销售;同时依托高标准的研发技术及产业化平台,为国内外新药企业及研发机构提供CRO/CMO服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082500001732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688247"],"gpt_icon":0},{"id":"2561325510","title":"每周股票复盘：宣泰医药（688247）股东户数减少，控股股东承诺不减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2561325510","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561325510?lang=zh_cn&edition=full","pubTime":"2025-08-24 07:36","pubTimestamp":1755992177,"startTime":"0","endTime":"0","summary":"截至2025年8月22日收盘，宣泰医药报收于12.21元，较上周的12.35元下跌1.13%。本周关注点股本股东变化：截至2025年6月30日，宣泰医药股东户数减少至8020户，减幅为4.4%。公司公告汇总：控股股东上海联和投资有限公司承诺未来24个月不减持公司股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082400002173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688247","BK0239"],"gpt_icon":0},{"id":"2560927422","title":"上海宣泰医药3110万股限售股将于8月25日解禁 控股股东自愿延长锁定期","url":"https://stock-news.laohu8.com/highlight/detail?id=2560927422","media":"中访网财观","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560927422?lang=zh_cn&edition=full","pubTime":"2025-08-18 00:02","pubTimestamp":1755446520,"startTime":"0","endTime":"0","summary":"来源：中访网财观中访网数据 上海宣泰医药科技股份有限公司公告，其首次公开发行的部分限售股将于2025年8月25日上市流通，解禁数量达3110.184万股，占公司总股本的68.61%。根据招股书承诺，上述股份限售期为上市后36个月。保荐机构国泰海通证券核查确认，相关股东均履行了限售承诺，本次解禁符合科创板规则。宣泰医药主营高端仿制药及创新药研发，此次限售股释放或对二级市场流动性产生影响，但控股股东延长锁定期或缓解短期抛压。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/cj/2025-08-18/doc-infminsr1932186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688247"],"gpt_icon":0},{"id":"2560245209","title":"宣泰医药：控股股东联和投资自愿承诺2年内不减持公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2560245209","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560245209?lang=zh_cn&edition=full","pubTime":"2025-08-17 16:47","pubTimestamp":1755420430,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["688247","BK0239"],"gpt_icon":0},{"id":"2558850048","title":"每周股票复盘：宣泰医药（688247）拟用不超8000万元闲置募资进行现金管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2558850048","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558850048?lang=zh_cn&edition=full","pubTime":"2025-08-10 05:34","pubTimestamp":1754775256,"startTime":"0","endTime":"0","summary":"截至2025年8月8日收盘，宣泰医药报收于12.03元，较上周的12.41元下跌3.06%。本周，宣泰医药8月5日盘中最高价报12.68元。本周关注点宣泰医药拟使用不超过8000万元闲置募集资金进行现金管理公司公告汇总宣泰医药召开会议审议通过了《关于使用部分闲置募集资金进行现金管理的议案》，同意在不影响募投项目建设和使用安排并有效控制风险前提下，合理使用不超过8000万元的部分闲置募集资金进行现金管理。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081000001245.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688247"],"gpt_icon":0},{"id":"2557578528","title":"宣泰医药：拟使用总额度不超8000万元的部分闲置募集资金进行现金管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2557578528","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557578528?lang=zh_cn&edition=full","pubTime":"2025-08-08 16:39","pubTimestamp":1754642396,"startTime":"0","endTime":"0","summary":"（原标题：宣泰医药(688247.SH)：拟使用总额度不超8000万元的部分闲置募集资金进行现金管理）格隆汇8月8日丨宣泰医药(688247.SH)公布，公司拟使用总额度不超过人民币8,000万元的部分闲置募集资金进行现金管理，使用期限为自公司董事会审议通过之日起12个月内。在前述额度及期限范围内，资金可以循环滚动使用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080817093894d760cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080817093894d760cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688247"],"gpt_icon":0},{"id":"2557451567","title":"熊去氧胆酸概念盘中跳水，吉贝尔跌0.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557451567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557451567?lang=zh_cn&edition=full","pubTime":"2025-08-08 09:47","pubTimestamp":1754617657,"startTime":"0","endTime":"0","summary":"08月08日，熊去氧胆酸概念盘中跳水，截至09点47分，熊去氧胆酸概念整体指数下跌1.01%，报1434.000点。从个股上来看，该概念的成分股中，吉贝尔跌0.90%，赛升药业、宣泰医药、华润双鹤跌幅居前。从资金上来看，截止发稿，熊去氧胆酸概念主力净流入为1587.87万，其中众生药业受到资金热捧，主力净流入6660.68万；拉长时间线来看，该板块近20日主力资金净流入-31.02亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808094737a47c0c90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808094737a47c0c90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688247","BK0239","688566","BK0010","600062","BK0175","BK0188","BK0185","BK0028"],"gpt_icon":0},{"id":"2557582940","title":"CRO概念盘中跳水，ST诺泰跌0.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557582940","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557582940?lang=zh_cn&edition=full","pubTime":"2025-08-07 10:12","pubTimestamp":1754532747,"startTime":"0","endTime":"0","summary":"08月07日，CRO概念盘中跳水，截至10点12分，CRO概念整体指数下跌1.06%，报584.320点。从个股上来看，该概念的成分股中，ST诺泰跌0.47%，宣泰医药、义翘神州、百诚医药跌幅居前。从资金上来看，截止发稿，CRO概念主力净流入为-4.80亿，其中凯莱英受到资金热捧，主力净流入644.65万；拉长时间线来看，该板块近20日主力资金净流入-69.78亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807101227a479d0d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807101227a479d0d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","688247","BK0239"],"gpt_icon":0},{"id":"2557467073","title":"熊去氧胆酸概念盘中跳水，宣泰医药跌0.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557467073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557467073?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:36","pubTimestamp":1754444214,"startTime":"0","endTime":"0","summary":"08月06日，熊去氧胆酸概念盘中跳水，截至09点36分，熊去氧胆酸概念整体指数下跌0.63%，报1483.800点。从个股上来看，该概念的成分股中，宣泰医药跌0.24%，跌幅居前。从资金上来看，截止发稿，熊去氧胆酸概念主力净流入为-1062.45万，其中千红制药受到资金热捧，主力净流入1764.58万；拉长时间线来看，该板块近20日主力资金净流入-19.38亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806093654a6d5759f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806093654a6d5759f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688247","BK0239"],"gpt_icon":0},{"id":"2556338836","title":"中证百度百发策略100指数上涨1.06%，前十大权重包含宣泰医药等","url":"https://stock-news.laohu8.com/highlight/detail?id=2556338836","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556338836?lang=zh_cn&edition=full","pubTime":"2025-08-04 23:07","pubTimestamp":1754320056,"startTime":"0","endTime":"0","summary":"数据统计显示，中证百度百发策略100指数近一个月上涨5.04%，近三个月上涨16.43%，年至今上涨18.21%。从中证百度百发策略100指数持仓的市场板块来看，上海证券交易所占比50.01%、深圳证券交易所占比49.99%。从中证百度百发策略100指数持仓样本的行业来看，工业占比30.43%、信息技术占比15.47%、金融占比13.59%、原材料占比11.03%、可选消费占比8.79%、通信服务占比5.95%、公用事业占比4.81%、医药卫生占比4.10%、能源占比2.79%、房地产占比2.05%、主要消费占比0.98%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/04230752196882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK4526","IE00B0JY6N72.USD","LU0173614495.USD","BK4602","BK4585","LU1023057109.AUD","LU1115378108.SGD","LU0359202008.SGD","688247","BK4588","BK4612","LU0640798160.USD","LU0359201612.USD","BK4552","BK4535","LU0287142896.SGD","BK4543","BK4574","BK4614","BK4504","BK4579","BK4531","BK4548","BK4514","BK4077","BK4587"],"gpt_icon":1},{"id":"2556879027","title":"熊去氧胆酸概念盘中跳水，华润双鹤跌2.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556879027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556879027?lang=zh_cn&edition=full","pubTime":"2025-08-04 09:47","pubTimestamp":1754272066,"startTime":"0","endTime":"0","summary":"08月04日，熊去氧胆酸概念盘中跳水，截至09点47分，熊去氧胆酸概念整体指数下跌2.11%，报1423.250点。从个股上来看，该概念的成分股中，华润双鹤跌2.55%，川宁生物、上海凯宝、宣泰医药跌幅居前。从资金上来看，截止发稿，熊去氧胆酸概念主力净流入为-1.19亿，其中海辰药业受到资金热捧，主力净流入5683.34万；拉长时间线来看，该板块近20日主力资金净流入-18.23亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804094746a4734328&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804094746a4734328&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600062","BK0028","BK0175","BK0188","688247","BK0185","BK0239","BK0010"],"gpt_icon":0},{"id":"2555882280","title":"熊去氧胆酸概念盘中跳水，宣泰医药跌0.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555882280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555882280?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:35","pubTimestamp":1753752957,"startTime":"0","endTime":"0","summary":"07月29日，熊去氧胆酸概念盘中跳水，截至09点35分，熊去氧胆酸概念整体指数下跌0.52%，报1379.610点。从个股上来看，该概念的成分股中，宣泰医药跌0.66%，海辰药业、白云山、赛托生物跌幅居前。从资金上来看，截止发稿，熊去氧胆酸概念主力净流入为-145.25万，其中众生药业受到资金热捧，主力净流入4128.98万；拉长时间线来看，该板块近20日主力资金净流入-18.00亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729093557a468949d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729093557a468949d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688247","BK0239"],"gpt_icon":0},{"id":"2554741744","title":"CRO概念盘中拉升，亚太药业涨7.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554741744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554741744?lang=zh_cn&edition=full","pubTime":"2025-07-28 09:35","pubTimestamp":1753666533,"startTime":"0","endTime":"0","summary":"07月28日，CRO概念盘中拉升，截至09点35分，CRO概念整体指数上涨0.52%，报570.230点。从个股上来看，该概念的成分股中，亚太药业涨7.82%，百诚医药、宣泰医药、南模生物涨幅居前。从资金上来看，截止发稿，CRO概念主力净流入为4700.06万，其中药明康德受到资金热捧，主力净流入5278.62万；拉长时间线来看，该板块近20日主力资金净流入-4.73亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728093533a4669ab8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728093533a4669ab8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0132","688247","688265","BK0239","002370"],"gpt_icon":0},{"id":"2554734214","title":"熊去氧胆酸概念盘中拉升，宣泰医药涨2.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554734214","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554734214?lang=zh_cn&edition=full","pubTime":"2025-07-25 09:35","pubTimestamp":1753407345,"startTime":"0","endTime":"0","summary":"07月25日，熊去氧胆酸概念盘中拉升，截至09点35分，熊去氧胆酸概念整体指数上涨0.71%，报1369.980点。从个股上来看，该概念的成分股中，宣泰医药涨2.96%，广生堂、九典制药、上海凯宝涨幅居前。从资金上来看，截止发稿，熊去氧胆酸概念主力净流入为-2496.50万，其中广生堂受到资金热捧，主力净流入968.58万；拉长时间线来看，该板块近20日主力资金净流入-18.52亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072509354594b968a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072509354594b968a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688247"],"gpt_icon":0},{"id":"2553224656","title":"上海国资改革概念盘中拉升，上海机电涨2.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553224656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553224656?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:35","pubTimestamp":1753320952,"startTime":"0","endTime":"0","summary":"07月24日，上海国资改革概念盘中拉升，截至09点35分，上海国资改革概念整体指数上涨0.60%，报3111.840点。从个股上来看，该概念的成分股中，上海机电涨2.38%，宣泰医药、云赛智联、开开实业涨幅居前。从资金上来看，截止发稿，上海国资改革概念主力净流入为1.14亿，其中隧道股份受到资金热捧，主力净流入6131.34万；拉长时间线来看，该板块近20日主力资金净流入-50.83亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724093552971ae95b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724093552971ae95b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0184","BK0201","BK0030","BK0111","BK0231","BK0099","BK0185","BK0061","BK0259","688247","BK0028","BK0188","BK0012","BK0130","600835","BK0196","600602","BK0020"],"gpt_icon":0},{"id":"2553288112","title":"熊去氧胆酸概念盘中拉升，赛升药业涨4.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553288112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553288112?lang=zh_cn&edition=full","pubTime":"2025-07-22 09:36","pubTimestamp":1753148213,"startTime":"0","endTime":"0","summary":"07月22日，熊去氧胆酸概念盘中拉升，截至09点36分，熊去氧胆酸概念整体指数上涨0.58%，报1363.650点。从个股上来看，该概念的成分股中，赛升药业涨4.95%，阿拉丁、宣泰医药、人福医药涨幅居前。从资金上来看，截止发稿，熊去氧胆酸概念主力净流入为-2606.95万，其中赛升药业受到资金热捧，主力净流入2371.84万；拉长时间线来看，该板块近20日主力资金净流入-13.50亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722093653a6b96a59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722093653a6b96a59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","688247","300485","BK0046","BK0070","BK0239","BK0012","BK0185","BK0096","BK0028","600079"],"gpt_icon":0},{"id":"2552175614","title":"每周股票复盘：宣泰医药（688247）股东减持及子公司通过欧盟GMP认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2552175614","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552175614?lang=zh_cn&edition=full","pubTime":"2025-07-20 03:34","pubTimestamp":1752953648,"startTime":"0","endTime":"0","summary":"截至2025年7月18日收盘，宣泰医药报收于11.72元，较上周的10.9元上涨7.52%。本周关注点公司公告汇总：持股5%以上股东计划减持不超过700万股，占公司总股本的1.5441%公司公告汇总：全资子公司江苏宣泰药业通过欧盟EMA的GMP认证公司公告汇总持股5%以上股东减持股份计划公告：截至公告披露日，股东南京市栖和创业投资合伙企业持有公司股份25,798,000股，占公司总股本的5.6907%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072000000784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["FSXEmain","688247","BK0239","FESXmain"],"gpt_icon":0},{"id":"2552045648","title":"宣泰医药涨5.02% 创新药研发与估值修复预期驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2552045648","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552045648?lang=zh_cn&edition=full","pubTime":"2025-07-18 11:21","pubTimestamp":1752808901,"startTime":"0","endTime":"0","summary":"宣泰医药股价大幅上涨，最新价11.92元/股，涨跌幅为5.02%。资金博弈与政策扰动共振近期宣泰医药净流出主要源于短期资金面与政策预期的多重博弈。技术转化与国际化双轮驱动宣泰医药的长期价值锚定于创新药研发成果转化与全球化布局。2024年CRO业务收入同比增长16.6%，3款抗肿瘤药物进入临床III期，研发管线进入价值释放关键期。但需警惕股东减持实施带来的阶段性抛压，以及创新药临床进展不及预期风险，这两大因素将共同决定股价中枢移动方向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718112151a6b11720&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718112151a6b11720&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688247","BK0239","159992"],"gpt_icon":0},{"id":"2552705109","title":"宣泰医药(688247.SH)子公司宣泰药业通过欧盟GMP认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2552705109","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552705109?lang=zh_cn&edition=full","pubTime":"2025-07-17 15:42","pubTimestamp":1752738138,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宣泰医药 发布公告，近日，公司全资子公司江苏宣泰药业有限公司收到匈牙利国家公共卫生和药房中心依据欧洲药品管理局相关法规颁发的《药品GMP证书》。宣泰药业本次通过欧盟EMA的GMP认证，是继其通过NMPA、FDA、PMDA、SFDA等药政当局GMP认证后又一次良好的认证记录，意味着公司质量体系始终保持与国际标准接轨。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1318924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","FSXEmain","688247","FESXmain"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1758237719463,"stockEarnings":[{"period":"1week","weight":-0.0018},{"period":"1month","weight":-0.1177},{"period":"3month","weight":0.1002},{"period":"6month","weight":0.0516},{"period":"1year","weight":0.4774},{"period":"ytd","weight":0.0914}],"compareEarnings":[{"period":"1week","weight":-0.0113},{"period":"1month","weight":0.028},{"period":"3month","weight":0.1404},{"period":"6month","weight":0.1387},{"period":"1year","weight":0.4101},{"period":"ytd","weight":0.1432}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海宣泰医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8020人(较上一季度减少4.40%)","perCapita":"56526股","listingDate":"2022-08-25","address":"上海市浦东新区中国(上海)自由贸易试验区蔡伦路780号7层709室","registeredCapital":"45334万元","survey":"　　上海宣泰医药科技股份有限公司的主营业务是高端仿制药研发与产业化及创新药CRO/CMO一体化服务。公司的主要产品是泊沙康唑肠溶片、美沙拉秦肠溶缓释片、马昔腾坦片、西格列汀二甲双胍缓释片、达格列净二甲双胍缓释片。","listedPrice":9.37},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"宣泰医药(688247)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供宣泰医药(688247)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"宣泰医药,688247,宣泰医药股票,宣泰医药股票老虎,宣泰医药股票老虎国际,宣泰医药行情,宣泰医药股票行情,宣泰医药股价,宣泰医药股市,宣泰医药股票价格,宣泰医药股票交易,宣泰医药股票购买,宣泰医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"宣泰医药(688247)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供宣泰医药(688247)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}